NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
424B3 - CERO THERAPEUTICS HOLDINGS, INC.
Filed:
2026-04-14
AccNo:
0001213900-26-043520
Size:
50 KB
发布时间04/14 20:03 UTC
首次发现04/14 20:07 UTC
热度102.7
重要度38
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 562 字符
Form 424B3 - Prospectus [Rule 424(b)(3)]: SEC Accession No. 0001213900-26-043520
Filing Date: 2026-04-14
Accepted: 2026-04-14 16:03:25
Documents: 2
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK : 0001870404 (see all company filings) EIN. : 871088814 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 424B3 | Act: 33 | File No.: 333-291984 | Film No.: 26860835 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)
1 | PROSPECTUS SUPPLEMENT | ea0286319-424b3_cero.htm | 424B3
2 | GRAPHIC | ea028631902_img1.jpg | GRAPHIC